Literature DB >> 8129606

Subclinical hormone secretion by incidentally discovered adrenal masses.

R H Caplan1, P J Strutt, G G Wickus.   

Abstract

OBJECTIVE: To determine the frequency of subclinical hormone secretion in incidentally discovered adrenal masses.
DESIGN: We reviewed the radiologic reports of 1779 consecutive computed tomographic scans of the chest, abdomen, and pelvis.
SETTING: Regional referral medical center. PATIENTS: Eighty-nine patients with abnormalities of one or both adrenal glands were identified. Patients with nonadrenal gland malignant neoplasms, primary aldosteronism, adrenal hemorrhage, and death or severe illness were not investigated. The final study group consisted of 26 patients with incidentally discovered adrenal masses. MAIN OUTCOME MEASURES: Aldosterone secretion was assessed by measuring plasma renin activity and the plasma aldosterone concentration in patients with unexplained hypokalemia. We evaluated cortisol secretion by performing a 1-mg overnight dexamethasone suppression test and by measuring the corticotropin concentration at 8 AM by a sensitive method. In patients with low corticotropin values, we also measured the 24-hour urinary excretion of free cortisol and 17-ketosteroids and assessed diurnal variation by measuring plasma cortisol concentrations at 8 AM and 4 PM. Adrenal medullary function was studied by measuring urinary free catecholamines.
RESULTS: One patient had unrecognized primary aldosteronism, two patients had elevated free catecholamine excretion, and three patients (12%) had subclinical Cushing's syndrome.
CONCLUSION: Based on our observations and a review of the literature, we conclude that subclinical hormone secretion, especially cortisol secretion, is more common in patients with incidentally discovered adrenal masses than previously appreciated. Surgeons and anesthesiologists must be alert to the possibility that adrenal insufficiency or a hypertensive crisis may develop in the perioperative period in patients with incidentally discovered adrenal masses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129606     DOI: 10.1001/archsurg.1994.01420270067016

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  22 in total

1.  Correlation between radiologic and pathologic dimensions of adrenal masses.

Authors:  Rafael Fajardo; Jorge Montalvo; David Velázquez; Jorge Arch; Paulina Bezaury; Rosa Gamino; Miguel F Herrera
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

Review 2.  Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.

Authors:  S Tsagarakis; D Vassiliadi; N Thalassinos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 3.  The clinical evaluation of silent adrenal masses.

Authors:  B Ambrosi; E Passini; T Re; L Barbetta
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

Review 4.  Endocrine incidentalomas--challenges imposed by incidentally discovered lesions.

Authors:  Dimitra A Vassiliadi; Stylianos Tsagarakis
Journal:  Nat Rev Endocrinol       Date:  2011-06-28       Impact factor: 43.330

Review 5.  Subclinical Cushing's syndrome.

Authors:  Massimo Terzolo; Giuseppe Reimondo; Silvia Bovio; Alberto Angeli
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

6.  Prevalence of adrenal incidentaloma in a contemporary computerized tomography series.

Authors:  S Bovio; A Cataldi; G Reimondo; P Sperone; S Novello; A Berruti; P Borasio; C Fava; L Dogliotti; G V Scagliotti; A Angeli; M Terzolo
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

7.  Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.

Authors:  Sung Hee Park; Myeong-Jin Kim; Joo Hee Kim; Joon Seok Lim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2007 Jul-Aug       Impact factor: 3.500

8.  Natural course of benign adrenal incidentalomas in subjects with extra-adrenal malignancy.

Authors:  Serkan Yener; Senem Ertilav; Mustafa Secil; Baris Akinci; Tevfik Demir; Abdurrahman Comlekci; Sena Yesil
Journal:  Endocrine       Date:  2009-04-21       Impact factor: 3.633

9.  Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass.

Authors:  F Donadio; V Morelli; A S Salcuni; C Eller-Vainicher; M Carletto; M Castellani; L Dellavedova; A Scillitani; P Beck-Peccoz; I Chiodini
Journal:  J Endocrinol Invest       Date:  2009-06-15       Impact factor: 4.256

Review 10.  [Adrenal gland tumors].

Authors:  H S Willenberg; D Zschucke; S R Bornstein
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.